{"id":"https://openalex.org/W2008441808","doi":"https://doi.org/10.1192/pb.26.5.172","title":"Use of atypical antipsychotics by consultant psychiatrists working in forensic settings","display_name":"Use of atypical antipsychotics by consultant psychiatrists working in forensic settings","publication_year":2002,"publication_date":"2002-05-01","ids":{"openalex":"https://openalex.org/W2008441808","doi":"https://doi.org/10.1192/pb.26.5.172","mag":"2008441808"},"language":"en","primary_location":{"id":"doi:10.1192/pb.26.5.172","doi":"https://doi.org/10.1192/pb.26.5.172","is_oa":true,"landing_page_url":"https://doi.org/10.1192/pb.26.5.172","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/9511113AC4C4FC96686C15F239CCC45E/S0955603600025332a.pdf/div-class-title-use-of-atypical-antipsychotics-by-consultant-psychiatrists-working-in-forensic-settings-div.pdf","source":{"id":"https://openalex.org/S68436342","display_name":"Psychiatric Bulletin","issn_l":"0955-6036","issn":["0955-6036","1472-1473","2053-4868","2053-4876"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4310311786","host_organization_name":"Royal College of Psychiatrists","host_organization_lineage":["https://openalex.org/P4310311786"],"host_organization_lineage_names":["Royal College of Psychiatrists"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatric Bulletin","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/9511113AC4C4FC96686C15F239CCC45E/S0955603600025332a.pdf/div-class-title-use-of-atypical-antipsychotics-by-consultant-psychiatrists-working-in-forensic-settings-div.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078724624","display_name":"Carol Paton","orcid":"https://orcid.org/0000-0001-7756-1031","observed_orcids":["https://orcid.org/0000-0001-7756-1031"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carol Paton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022668330","display_name":"J. Alves Garcia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jose A. Garcia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109402983","display_name":"Deborah Brooke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285714368","display_name":"Oxleas NHS Foundation Trust","ror":"https://ror.org/033t2dn25","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1285714368"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Deborah Brooke","raw_affiliation_strings":["The Bracton Centre, Oxleas NHS Trust, Bexley Hospital, Old Bexley Lane, Bexley, Kent DA5 2BF"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Bracton Centre, Oxleas NHS Trust, Bexley Hospital, Old Bexley Lane, Bexley, Kent DA5 2BF","institution_ids":["https://openalex.org/I1285714368"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5109402983"],"corresponding_institution_ids":["https://openalex.org/I1285714368"],"apc_list":null,"apc_paid":null,"fwci":0.3648,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.61940745,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"26","issue":"5","first_page":"172","last_page":"174"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9047999978065491,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9047999978065491,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10565","display_name":"Psychopathy, Forensic Psychiatry, Sexual Offending","score":0.04690000042319298,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11678","display_name":"Healthcare Decision-Making and Restraints","score":0.018799999728798866,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":1.0},{"id":"https://openalex.org/keywords/forensic-psychiatry","display_name":"forensic psychiatry","score":0.9860000014305115},{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.7279999852180481},{"id":"https://openalex.org/keywords/long-acting-injectable-antipsychotics","display_name":"long-acting injectable antipsychotics","score":0.8510000109672546},{"id":"https://openalex.org/keywords/polypharmacy","display_name":"polypharmacy","score":0.9760000109672546},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.7850000262260437},{"id":"https://openalex.org/keywords/psychoeducation","display_name":"psychoeducation","score":0.8629999756813049}],"concepts":[{"id":"https://openalex.org/C36434225","wikidata":"https://www.wikidata.org/wiki/Q1895998","display_name":"Polypharmacy","level":2,"score":0.8109606504440308},{"id":"https://openalex.org/C2780477327","wikidata":"https://www.wikidata.org/wiki/Q2115980","display_name":"Psychoeducation","level":3,"score":0.7367721796035767},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6367409825325012},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5880840420722961},{"id":"https://openalex.org/C2781035948","wikidata":"https://www.wikidata.org/wiki/Q1407263","display_name":"Forensic psychiatry","level":2,"score":0.4414585530757904},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.13853469491004944},{"id":"https://openalex.org/C27415008","wikidata":"https://www.wikidata.org/wiki/Q7256382","display_name":"Psychological intervention","level":2,"score":0.11532860994338989}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1192/pb.26.5.172","doi":"https://doi.org/10.1192/pb.26.5.172","is_oa":true,"landing_page_url":"https://doi.org/10.1192/pb.26.5.172","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/9511113AC4C4FC96686C15F239CCC45E/S0955603600025332a.pdf/div-class-title-use-of-atypical-antipsychotics-by-consultant-psychiatrists-working-in-forensic-settings-div.pdf","source":{"id":"https://openalex.org/S68436342","display_name":"Psychiatric Bulletin","issn_l":"0955-6036","issn":["0955-6036","1472-1473","2053-4868","2053-4876"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4310311786","host_organization_name":"Royal College of Psychiatrists","host_organization_lineage":["https://openalex.org/P4310311786"],"host_organization_lineage_names":["Royal College of Psychiatrists"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatric Bulletin","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1192/pb.26.5.172","doi":"https://doi.org/10.1192/pb.26.5.172","is_oa":true,"landing_page_url":"https://doi.org/10.1192/pb.26.5.172","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/9511113AC4C4FC96686C15F239CCC45E/S0955603600025332a.pdf/div-class-title-use-of-atypical-antipsychotics-by-consultant-psychiatrists-working-in-forensic-settings-div.pdf","source":{"id":"https://openalex.org/S68436342","display_name":"Psychiatric Bulletin","issn_l":"0955-6036","issn":["0955-6036","1472-1473","2053-4868","2053-4876"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4310311786","host_organization_name":"Royal College of Psychiatrists","host_organization_lineage":["https://openalex.org/P4310311786"],"host_organization_lineage_names":["Royal College of Psychiatrists"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatric Bulletin","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320338413","display_name":"Cilag","ror":"https://ror.org/02fe4h741"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2008441808.pdf","grobid_xml":"https://content.openalex.org/works/W2008441808.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W2014933302","https://openalex.org/W2023446745","https://openalex.org/W2062250724","https://openalex.org/W2085360366","https://openalex.org/W2096635847","https://openalex.org/W2102618984","https://openalex.org/W2151893425","https://openalex.org/W2268785127","https://openalex.org/W2960479563","https://openalex.org/W3133633445"],"related_works":["https://openalex.org/W2115955114","https://openalex.org/W2151893425","https://openalex.org/W2148906169","https://openalex.org/W2474357122","https://openalex.org/W2063940667","https://openalex.org/W1970545487","https://openalex.org/W2051592815","https://openalex.org/W2557520378","https://openalex.org/W2086892539","https://openalex.org/W3016216973"],"abstract_inverted_index":{"AIMS":[0],"AND":[1],"METHOD":[2],"Atypical":[3],"antipsychotics":[4,73,93],"have":[5],"less":[6],"neurological":[7],"side-effects":[8,63,111],"than":[9],"the":[10,42,58,62,65,110],"older":[11],"drugs":[12],"but":[13],"are":[14],"only":[15],"available":[16],"as":[17,94],"oral":[18],"preparations.":[19],"This":[20],"may":[21,108],"limit":[22],"their":[23,46],"use":[24],"in":[25,38,41,98],"forensic":[26,39,99],"patients.":[27],"We":[28],"sent":[29],"a":[30],"postal":[31],"questionnaire":[32],"to":[33,44,56,84,122],"all":[34],"consultant":[35],"psychiatrists":[36],"working":[37],"settings":[40],"UK":[43],"determine":[45],"views.":[47],"RESULTS":[48],"The":[49,68,101],"response":[50],"rate":[51],"was":[52],"60%.":[53],"Respondents":[54],"tended":[55],"overestimate":[57],"benefits":[59],"and":[60,74,78,115,124],"underestimate":[61],"of":[64,103,112],"atypical":[66,72,92,116],"antipsychotics.":[67,117],"majority":[69],"often":[70],"prescribed":[71],"depots":[75],"together.":[76],"Psychoeducation":[77],"serum":[79],"level":[80],"monitoring":[81],"were":[82],"used":[83],"optimise/monitor":[85],"compliance":[86],"by":[87],"50%.":[88],"CLINICAL":[89],"IMPLICATIONS":[90],"Using":[91],"monotherapy":[95],"is":[96],"problematic":[97],"settings.":[100],"extent":[102],"polypharmacy":[104],"means":[105],"that":[106],"patients":[107],"experience":[109],"both":[113],"typical":[114],"More":[118],"could":[119],"be":[120],"done":[121],"facilitate":[123],"monitor":[125],"compliance.":[126]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}